Related Experiment Videos
Oral hypoglycaemic agent failure
S Banerjee1, K Sinharoy, A K Singh
1Department of Medicine, NRS Medical College, Kolkata 700014.
Abstract:
Type 2 diabetic patients initially respond satisfactorily to diet, exercise and oral hypoglycaemic agents (OHA), but a fraction of them acquires resistance to drugs, right from the beginning (primary OHA failure) or in due course of time (secondary OHA failure) and becomes insulin requiring ultimately. Poor diet compliance and deterioration of beta-cell function are major causes of OHA failure and annual incidence is 3 to 30%. Keeping in mind the benefit of organ salvage in diabetes, failure with OHA treatment should be detected earliest and necessary measures adopted as early as possible. Recognition, appraisal and assessment of total problem can help a diabetic to enjoy a normal life.
Insights
Type 2 diabetes patients may develop resistance to oral hypoglycaemic agents (OHA), leading to insulin dependence. Early detection of OHA failure, caused by poor diet compliance and beta-cell function decline, is crucial for managing diabetes.
Area of Science:
- Endocrinology
- Metabolic Diseases
- Pharmacology
Background:
- Type 2 diabetes management often involves diet, exercise, and oral hypoglycaemic agents (OHA).
- A significant portion of patients develop primary or secondary resistance to OHA, necessitating insulin therapy.
- Poor adherence to dietary recommendations and declining beta-cell function are primary drivers of OHA failure.
Purpose of the Study:
- To highlight the importance of early detection of oral hypoglycaemic agent failure in type 2 diabetes.
- To emphasize the need for timely intervention to prevent disease progression and complications.
- To underscore the role of comprehensive patient assessment in optimizing diabetes management.
Main Methods:
- This study is a review of existing literature on OHA failure in type 2 diabetes.
- It analyzes the causes and incidence rates of primary and secondary OHA failure.
- The focus is on the clinical implications and management strategies for OHA failure.
Main Results:
- The annual incidence of OHA failure ranges from 3% to 30%.
- Primary and secondary OHA failure are significant challenges in achieving long-term glycemic control.
- Deterioration of beta-cell function and poor diet compliance are identified as key contributing factors.
Conclusions:
- Early recognition and assessment of OHA failure are critical for effective diabetes management.
- Prompt therapeutic adjustments can help preserve beta-cell function and potentially delay insulin requirement.
- Comprehensive management strategies are essential for patients to lead normal lives despite diabetes.